OvaScience to Host Third Quarter 2017 Financial Results Conference Call
October 26 2017 - 4:02PM
Business Wire
OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the
discovery, development and commercialization of new treatment
options, announced today that it will host a conference call at
4:30 p.m. ET on Thursday, November 2, 2017 to discuss third quarter
2017 financial results and provide a general corporate update.
The conference call may be accessed by dialing +1-888-424-8151
for U.S. callers and +1-847-585-4422 for international callers five
minutes prior to the start of the call and providing the passcode
9200599. A live webcast of the conference call will be available
online from the Investors section of the Company’s website at
www.ovascience.com.
A replay of the conference call will be available from 7:00 p.m.
ET on Thursday, November 2, 2017, through 11:59 p.m. ET on
Thursday, November 16, 2017, and may be accessed by visiting
OvaScience’s website or by dialing 1-888-843-7419 for U.S. callers
and 1-630-652-3042 for international callers. The replay access
code is 9200599#.
About OvaScienceOvaScienceSM, Inc. (NASDAQ:OVAS) is a
fertility company dedicated to improving treatment options for
women around the world. OvaScience is discovering, developing and
commercializing new fertility treatments because it believes women
deserve more options. Each OvaScience treatment is based on the
Company’s proprietary technology platform that leverages the
breakthrough discovery of egg precursor (EggPCSM) cells – immature
egg cells found inside the protective ovarian lining. OvaScience is
developing OvaPrimeSM, which could increase a woman’s egg reserve
and OvaTureSM, a potential in vitro fertilization (IVF) treatment
that could help a woman produce healthy, fertilizable eggs without
hormone injections. OvaScience’s AUGMENTSM treatment, a fertility
option designed to improve IVF success rates, is available in
certain IVF clinics in Canada. OvaScience treatments are not
available in the United States. For more information, visit
www.ovascience.com.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171026006173/en/
Media and Investor Contact:OvaScienceJennifer Viera,
617-420-8748jviera@ovascience.com
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Sep 2023 to Sep 2024